Acute Respiratory Distress Syndrome Clinical Trial
To survey the prevalence and the mortality of the Acute Lung Injury/ Acute Respiratory Distress Syndrome (ALI/ARDS) in 12 university hospital ICUs in Shanghai.
Acute lung injury is a critical illness syndrome consisted of acute hypoxemic respiratory
failure with bilateral pulmonary infiltrates that are not attributed to left atrial
hypertension. The severity of the hypoxemia differentiates these two entities, with a ratio
of partial pressure of oxygen in arterial blood (PaO2) to inspired fraction of oxygen (FIO2)
of less than 200 mm Hg for ARDS and of less than 300 mm Hg for ALI.[1] Although ARDS
initially was reported in 1967 by Ashbaugh and colleagues[2], it was not until 1992 that the
American-European Consensus Conference (AECC) on ARDS developed a standardized definition for
ARDS and ALI. There are many epidemiologic researches about the incidence and mortality of
the ALI/ARDS.[3-6] Gorden D [3] reported that a total of 1113 King County residents
undergoing mechanical ventilation met the criteria for acute lung injury and were 15 years of
age or older. On the basis of this figure, the crude incidence of acute lung injury was 78.9
per 100,000 person-years and the age-adjusted incidence was 86.2 per 100,000 person-years.
The in-hospital mortality rate was 38.5 percent. In our country, Yueming Lu [7] reported
in-hospital and 90-day mortalities of ARDS patients were 68.5 and 70.4% in Shanghai ICU in
2004.
In recent years, significant progress has been made in the diagnosis and treatment of the
ALI/ARDS, such as the application of the lung protective ventilation strategy and the CRRT,
which may prove the symptoms and the prognosis of the ALI/ARDS. However, controversies still
remained. Ventilation drive pressure, early application of neuromuscular blockade, strategy
of PEEP level are frequently met questions in routine practice. In our country, a guideline
for the treatment and diagnosis of ALI/ARDS was developed in 2006 [8]. So the incidence and
the mortality of this disease are unknown in our country now. Therefore, the investigators
will perform a prospective, multi-center study to survey the incidence, risk factors and
outcome of ALI/ARDS in 13 adult ICU in Shanghai.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
| Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
| Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
| Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
| Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
| Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
| Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
| Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
| Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
| Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
| Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
| Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
| Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
| Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
| Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
| Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
| Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
| Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A |